Activity of N-(2-phenylethyl)-N-n-propyl-2-(3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands. 1994

F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
Department of Chemical Sciences, University of Camerino, MC, Italy.

The N-n-propyl-N-(2-phenylethyl)-2-(3-hydroxyphenyl)ethylamine (1, RU 24213) had been previously identified as selective agonist of DA D2 receptor subtype. In this paper we describe the synthesis and in vitro binding affinities of several derivatives of 1 substituted with fluorine, chlorine and methyl or hydroxy groups on the phenyl ring of the N-2-phenylethyl moiety. The results obtained indicate that these substitutions do not improve the D2 binding affinity. The introduction on the phenyl ring of two fluorine or chlorine atoms decreases with D1 affinity, and the dichloro derivatives are highly selective for the D2 receptor. Preliminary behavioural tests confirm that the dichloro derivatives behave as D2 selective agonists.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D005021 Ethylamines Derivatives of ethylamine (the structural formula CH3CH2NH2).
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone
D013239 Stereotyped Behavior Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior, Stereotyped,Behaviors, Stereotyped,Stereotyped Behaviors

Related Publications

F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
January 1992, Drug design and discovery,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
November 1992, Journal of medicinal chemistry,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
April 1995, Archiv der Pharmazie,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
August 1984, Journal of medicinal chemistry,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
March 1990, Journal of medicinal chemistry,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
February 1985, The Journal of pharmacology and experimental therapeutics,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
November 1982, The Journal of pharmacology and experimental therapeutics,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
November 1987, Journal of medicinal chemistry,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
April 1972, Il Farmaco; edizione scientifica,
F Claudi, and M Cardellini, and A Di Stefano, and G Giorgioni, and F Cantalamessa, and F Renò, and W Balduini
January 1987, Journal of medicinal chemistry,
Copied contents to your clipboard!